Radiance Medspa

Has any government agency taken action against Radiance Medspa over GLP-1 drugs?

Radiance Medspa is named in 2 actions in this index: Connecticut Attorney General, settlement, May 6, 2026; Connecticut Attorney General, cease and desist letters (allegations, not findings), Dec 3, 2025. Of the FDA GLP-1 warning letters and openFDA recall reports in this index as of Nov 15, 2026, none is addressed to a firm under this name.

FDA records were matched by exact name only. A firm can appear in FDA records under a different legal name.

Place the releases give
Avon, CT
Actions in this index
2
Latest release
May 6, 2026

Records

Release
May 6, 2026Connecticut Attorney GeneralSettlementSemaglutide, Tirzepatideportal.ct.gov
Dec 3, 2025Connecticut Attorney GeneralCease and desist letters (allegations, not findings)Semaglutide, Tirzepatideportal.ct.gov

What each release says

Other firms named in the same releases are listed on the enforcement page.

This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.